Skip to content

SARX

Active
Private limited companyfounded 201115 yrs activeZwaanhof 1, 8800 Roeselare, BelgiumKBO/BCE: BE 0834.620.959

SARX has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €209k and a net result of €352k. Equity is growing by ~3.1% per year across the filed fiscal years. Its solvency ranks better than 29% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
84 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency60▼-2
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €17k at 30 days acceptable
Liquidity ample (current ratio 1.58 against 1.65 in 2024; short-term debt: 59% and cash: 47.3% of total assets), but 64.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
35.3%
Return on assets
59.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 15 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
28 d late
2024
25 d late
2023
22 d late
2022
25 d late
2021
18 d early
2020
85 d early
2019
43 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€209k▲ 0.2%
2024 · €209k
2018: €108k 2019: €162k 2020: €162k 2021: €109k 2022: €56k 2023: €56k 2024: €209k
2018 → 2025
Total assets
€593k▲ 4.8%
2024 · €566k
2018: €531k 2019: €382k 2020: €421k 2021: €479k 2022: €291k 2023: €446k 2024: €566k
2018 → 2025
Net result
€352k▲ 9.8%
2024 · €321k
2018: €273k 2019: €254k 2020: €242k 2021: €285k 2022: €333k 2023: €356k 2024: €321k
2018 → 2025
Working capital
€201k▼ 0.2%
2024 · €202k
2018: €102k 2019: €155k 2020: €155k 2021: €109k 2022: €56k 2023: €58k 2024: €202k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€109k-€56k▼ 48.9%€56k=€209k▲ 274%€209k▲ 0.2%
Operating result€373k-€438k▲ 17.6%€472k▲ 7.6%€448k▼ 5.1%€468k▲ 4.5%
Net result€285k-€333k▲ 16.8%€356k▲ 6.8%€321k▼ 9.8%€352k▲ 9.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400kOperating result 2021: €373k€373kNet result 2021: €285k€285kOperating result 2022: €438k€438kNet result 2022: €333k€333kOperating result 2023: €472k€472kNet result 2023: €356k€356kOperating result 2024: €448k€448kNet result 2024: €321k€321kOperating result 2025: €468k€468kNet result 2025: €352k€352k20212022202320242025
The operating result recovers in 2025; 2025 is 4% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €593k
Fixed assets €41k▼ 22.1%
Current assets €551k▲ 7.5%
Equity and liabilities €593k
Equity €209k▲ 0.2%
Debt €384k▲ 7.4%
The debt ratio rises from 63.1% to 64.7%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€480k
2024 · €458k
Cash flow
€365k
2024 · €332k
Solvency
35.3%
2024 · 36.9%
Current ratio
1.58
2024 · 1.65
Quick ratio
1.58
2024 · 1.65
Debt / equity
1.84
2024 · 1.71
ROE
168.6%
2024 · 153.8%
ROA
59.5%
2024 · 56.7%
Interest coverage
80.03
2024 · 70.21
Debt
€384k
2024 · €357k
Debt ≤ 1 year
€350k
2024 · €311k
Debt > 1 year
€30k
2024 · €43k
Income taxes
€115k
2024 · €123k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€566k€593k
Fixed assets21/28€53k€41k
Tangible fixed assets22/27€53k€40k
Leasing and similar rights25€53k€40k
Financial fixed assets28-€1k
Current assets29/58€512k€551k
Amounts receivable within one year40/41€2k€0
Trade receivables40€2k€0
Other amounts receivable41€0-
Current investments50/53-€125k
Cash at bank and in hand54/58€364k€280k
Deferred charges and accrued income490/1€147k€146k
Equity and liabilities
Total equity and liabilities10/49€566k€593k
Equity10/15€209k€209k
Contributions10/11€56k€56k=
Reserves13€153k€153k
Distributable reserves133€153k€153k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€357k€384k
Amounts payable after more than one year17€43k€30k
Financial debts170/4€43k€30k
Amounts payable within one year42/48€311k€350k
Current portion of amounts payable after more than one year42€12k€12k
Trade debts44€2k€2k
Suppliers440/4€2k€2k
Taxes, remuneration and social security45€56k€5k
Taxes450/3€56k€5k
Other amounts payable47/48€240k€331k
Accrued charges and deferred income492/3€4k€4k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11k€13k
Other operating charges640/8€786€448
Gross operating margin9900€459k€481k
Operating profit (loss)9901€448k€468k
Financial income75/76B€3k€6k
Recurring financial income75€3k€6k
Financial charges65/66B€7k€6k
Recurring financial charges65€7k€6k
Profit (loss) for the period before taxes9903€444k€467k
Income taxes67/77€123k€115k
Profit (loss) for the period9904€321k€352k
Profit (loss) for the period to be appropriated9905€321k€352k
Appropriation of the result
Profit (loss) to be appropriated9906€321k€352k
Transfer to equity691/2€153k€332
To other reserves6921€153k€332
Profit to be distributed694/7€168k€352k
Return on contributions (dividend)694€168k€352k

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
28-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
25-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 25 days late
2024
31-12
Financial Equity above €200kEq €209k ▲274%
7 profitable years in a row build equity to €209k.
22-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 22 days late
2023
31-12
Financial Highest result since 2018net €356k ▲6.8%
Operating result €472k, net result €356k, both a record.
25-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 25 days late
2022
13-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
07-05
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Weakest financial yearnet €242k ▼4.6%
Net result drops to €242k, the lowest in the series; recovery starts the following year.
18-06
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Equity above €150kEq €162k ▲50.1%
2 profitable years in a row build equity to €162k.
20-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 20 days late
2018
18-05
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
23-06
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Roeselare · 1 establishment unit since 2011
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Zwaanhof 18800 Roeselare
Ground area
2,186 m²
Building footprint
268 m²
Volume, LiDAR
1,525 m³
Parcel 36502B0567/00P000, Flanders · tallest building 16.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
SARX
Zwaanhof 1, 8800 RoeselareSpecialist medical practice
since 20112.197.474.226
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
36502B0567/00P000 Flanders 2,186 m² 1 · 268 m² 16.4 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2023 · 1 entry · 1,185 EUR awarded · 1,185 EUR paid
Year Entries awardedpaid
2023 1 1,185 EUR1,185 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 1,185 EUR · 1,185 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 6,657 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded17-03-2011
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers

Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.